Basal | ERBB2 | Luminal Aa | Luminal Ab | Luminal B | Normal-like | p-value | |
---|---|---|---|---|---|---|---|
ER-positive N = 84 | 3 | 4 | 43 (%)x | 21(%)x | 3 | 7 | 3 cases non evaluable |
Grade I | 1 | 0 | 14(32.5%) | 0 | 0 | 5 | 4.710 -6 |
Grade II | 0 | 0 | 24(55.8%) | 7(30%) | 0 | 2 | |
Grade III | 2 | 4 | 5(11.6%) | 14(66.6%) | 3 | 0 | |
VPI positive | 0 | 1 | 20/42 (47.6%) | 10/21 (47.6%) | 3 | 1 | |
Positive lymph nodes | 1 | 2 | 26/43 (60.4%) | 15/21 (71.4%) | 2 | 2 | |
AR positive | 1 | 2 | 31/36(86%) | 15/21(71.4%) | 2 | 3 | |
BCL2 positive | 2 | 2 | 36/39 (92.3%) | 14/15 (93%) | 2 | 6/6 (100%) | |
CCND1 Positive | 2 | 0 | 26/41 (63,4%) | 13/19 (68%) | 2 | 2/5 | |
ERBB2 (2+/3+) | 0 | 3 (3+) | 3/43 (6.9%) | 0 | 1(2+) | 0 | |
FOX A1 positive | 1 | 3 | 38/39 (97.4%) | 19/19 (100% | 3 | 4/5 | |
GATA3 Positive | 0 | 1 | 29/36 (80.5%) | 12/18 (66.6%) | 3 | 4/5 | |
Ki67 > 20% | 1 | 0 | 2/40(5%) | 5/18(27.7%) | 0 | 0 | 0.02 |
P53 positive | 2 | 2 | 8/42 (19%) | 4/20 (20%) | 1 | 0/6 | |
PR positive | 0 | 0 | 37/43 (86%) | 16/20 (80%) | 2 | 5/6 |